These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 37930174)

  • 1. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
    Neill B; Romero AR; Fenton OS
    ACS Appl Bio Mater; 2024 Aug; 7(8):4894-4913. PubMed ID: 37930174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery.
    Sunoqrot S; Abdel Gaber SA; Abujaber R; Al-Majawleh M; Talhouni S
    ACS Appl Bio Mater; 2024 Aug; 7(8):4998-5019. PubMed ID: 38236081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy.
    Oberli MA; Reichmuth AM; Dorkin JR; Mitchell MJ; Fenton OS; Jaklenec A; Anderson DG; Langer R; Blankschtein D
    Nano Lett; 2017 Mar; 17(3):1326-1335. PubMed ID: 28273716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Biomaterials for mRNA Delivery to Immune Cells.
    Isaac I; Bhatia M; Bhattacharya C
    ACS Appl Bio Mater; 2024 Aug; 7(8):5136-5146. PubMed ID: 39058246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA.
    Perche F; Benvegnu T; Berchel M; Lebegue L; Pichon C; Jaffrès PA; Midoux P
    Nanomedicine; 2011 Aug; 7(4):445-53. PubMed ID: 21220051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mRNA vaccines and their delivery strategies: A journey from infectious diseases to cancer.
    Malla R; Srilatha M; Farran B; Nagaraju GP
    Mol Ther; 2024 Jan; 32(1):13-31. PubMed ID: 37919901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy.
    Qi S; Zhang X; Yu X; Jin L; Yang K; Wang Y; Feng Y; Lei J; Mao Z; Yu G
    Adv Mater; 2024 Jun; 36(23):e2311574. PubMed ID: 38433564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress in mRNA cancer vaccines.
    Yao R; Xie C; Xia X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2307187. PubMed ID: 38282471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating nanoparticulate-personalized cancer vaccines into clinical applications: case study with RNA-lipoplexes for the treatment of melanoma.
    Grabbe S; Haas H; Diken M; Kranz LM; Langguth P; Sahin U
    Nanomedicine (Lond); 2016 Oct; 11(20):2723-2734. PubMed ID: 27700619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M; Li Y; Bloomer H; Xu Q
    Acc Chem Res; 2021 Nov; 54(21):4001-4011. PubMed ID: 34668716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Nanoparticle-Based Delivery Platforms for mRNA Vaccines for Treating Cancer.
    Lin Y; Chen X; Wang K; Liang L; Zhang H
    Vaccines (Basel); 2024 Jun; 12(7):. PubMed ID: 39066365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.
    Phua KK
    J Immunol Res; 2015; 2015():680620. PubMed ID: 26819957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Path towards mRNA delivery for cancer immunotherapy from bench to bedside.
    Chen W; Zhu Y; He J; Sun X
    Theranostics; 2024; 14(1):96-115. PubMed ID: 38164145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond.
    Estapé Senti M; García Del Valle L; Schiffelers RM
    Adv Drug Deliv Rev; 2024 Mar; 206():115190. PubMed ID: 38307296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA vaccines for cancer immunotherapy.
    Vishweshwaraiah YL; Dokholyan NV
    Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced nanoscale delivery systems for mRNA-based vaccines.
    Mobasher M; Ansari R; Castejon AM; Barar J; Omidi Y
    Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130558. PubMed ID: 38185238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymer-Based mRNA Delivery Strategies for Advanced Therapies.
    Yang W; Mixich L; Boonstra E; Cabral H
    Adv Healthc Mater; 2023 Jun; 12(15):e2202688. PubMed ID: 36785927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mRNA vaccine delivery using lipid nanoparticles.
    Reichmuth AM; Oberli MA; Jaklenec A; Langer R; Blankschtein D
    Ther Deliv; 2016; 7(5):319-34. PubMed ID: 27075952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Messenger RNA (mRNA) nanoparticle tumour vaccination.
    Phua KK; Nair SK; Leong KW
    Nanoscale; 2014 Jul; 6(14):7715-29. PubMed ID: 24904987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.